HF
ECYT

HRT Financial’s Endocyte, Inc. Common Stock ECYT Stock Holding History

HRT Financial’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,912
Closed -$211K – 818
2018
Q3 		$211K Buy
+11,912
New +$205K 0.03% 319

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

HRT Financial's ECYT Position: Q4 2018 in Review

HRT Financial sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 11,912 shares — an estimated $211K sold.

HRT Financial first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $211K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • HRT Financial reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • HRT Financial sold 11,912 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $211K.
  • HRT Financial first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • HRT Financial's Endocyte, Inc. Common Stock position peaked at $211K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on HRT Financial's 13F filing for Q4 2018, filed 15 Feb 2019.